Global healthcare company Bayer has selected four digital health start-ups from around the globe to help develop their ideas.
The start-ups were selected as part of the Grants4Apps (G4A) Accelerator in Berlin, developed to bring digital health solutions to patients. The accelerator received over 450 digital-health related applications from over 61 countries.
The four start-ups were awarded €50,000 and will be mentored by Bayer senior managers and external experts to help develop their business models and products until late November.
The companies, which have projects in areas such as medical adherence, endometriosis, atrial fibrillation, deep vein thrombosis and ultrasound diagnostics, have now moved into the G4A Accelerator premises at Bayer’s pharmaceutical division in Berlin.
Reinhard Franzen, head of Bayer Pharmaceuticals Commercial Operations Europe, Middle East and Africa, said: “We recognise the huge creative potential outside of Bayer and we believe that combining expertise is key to innovation and success. The Grants4Apps Accelerator offers new partnership opportunities in the digital health area with its vibrant development in the past years. We are very excited to welcome the four new start-ups for 2017.”
The selected start-ups include ThinkSono and aparito from the UK, Oratel Diagnostics from the US and Sky Labs from South Korea.
